Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 11 January 1974:
Vol. 183. no. 4120, pp. 90 - 91
DOI: 10.1126/science.183.4120.90
Prev | Table of Contents | Next

Articles

Creutzfeldt-Jakob Disease: Focus among Libyan Jews in Israel

Esther Kahana 1, Milton Alter 2, Jackson Braham 3, and Dov Sofer 4

1 Neurology Service, Barzilai Medical Center, Ashkelon, Israel
2 Epidemiology and Genetics Unit, Departnent of Neurology, University of Minnesota, Minneapolis 55455
3 Department of Neurology, Chaim Sheba Medical Center. Tel Hashomer, Israel
4 Departm1ent of Neurology, Hadassah-Hebrew University Hospital. Jerusalem, Israel

A countrywide search for Creutzfeldt-Jakob disease in Israel disclosed 29 cases with onset between 1963 and 1972. Incidence in various ethnic groups varied in the narrow range of 0.4 to 1.9 per million population except among Jewish immigrants from Libya, among whom the incidence was 31.3 per million. An extraordinary excess of Creutzfeldt-Jakob disease exists in this ethnic group.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers.
H. Lee, H. Rosenmann, J. Chapman, P. B. Kingsley, C. Hoffmann, O. S. Cohen, E. Kahana, A. D. Korczyn, and I. Prohovnik (2009)
Brain 132, 2680-2687
   Abstract »    Full Text »    PDF »
Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease cluster.
G. M. Klug, H. Wand, A. Boyd, M. Law, S. Whyte, J. Kaldor, C. L. Masters, and S. Collins (2009)
Brain 132, 493-501
   Abstract »    Full Text »    PDF »
MR Imaging of Familial Creutzfeldt-Jakob Disease: A Blinded and Controlled Study.
R.K. Fulbright, C. Hoffmann, H. Lee, A. Pozamantir, J. Chapman, and I. Prohovnik (2008)
AJNR Am. J. Neuroradiol. 29, 1638-1643
   Abstract »    Full Text »    PDF »
Induced Neuroprotection Independently From PrPSc Accumulation in a Mouse Model for Prion Disease Treated With Simvastatin.
Y. Haviv, D. Avrahami, H. Ovadia, T. Ben-Hur, R. Gabizon, and R. Sharon (2008)
Arch Neurol 65, 762-775
   Abstract »    Full Text »    PDF »
A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom: Analysis of clustering.
L. Linsell, S. N. Cousens, P. G. Smith, R. S.G. Knight, M. Zeidler, G. Stewart, R. de Silva, T. F.G. Esmonde, H. J.T. Ward, and R. G. Will (2004)
Neurology 63, 2077-2083
   Abstract »    Full Text »    PDF »
Creutzfeldt-Jakob disease in Australia 1970-1999.
S. Collins, A. Boyd, J. S. Lee, V. Lewis, A. Fletcher, C. A. McLean, M. Law, J. Kaldor, M. J. Smith, and C. L. Masters (2002)
Neurology 59, 1365-1371
   Abstract »    Full Text »    PDF »
Neurodegenerative Diseases and Prions.
S. B. Prusiner (2001)
N. Engl. J. Med. 344, 1516-1526
   Full Text »    PDF »
Is there evidence for exogenous risk factors in the aetiology and spread of Creutzfeldt-Jakob disease?.
C. E. M. Hillier and R. L. Salmon (2000)
QJM 93, 617-631
   Full Text »    PDF »
Prions.
S. B. Prusiner (1998)
PNAS 95, 13363-13383
   Abstract »    Full Text »    PDF »
Molecular Biology and Genetics of Prion Diseases.
S.B. Prusiner (1996)
Cold Spring Harb Symp Quant Biol 61, 473-493
   Abstract »    PDF »
Genetic and Infectious Prion Diseases.
S. B. Prusiner (1993)
Arch Neurol 50, 1129-1153
   Abstract »    PDF »
Molecular biology of prion diseases.
S. Prusiner (1991)
Science 252, 1515-1522
   Abstract »    PDF »
Descriptive Epidemiology of Creutzfeldt-Jakob Disease in Chile.
S. Galvez, C. Masters, and D. C. Gajdusek (1980)
Arch Neurol 37, 11-14
   Abstract »    PDF »
Unconventional viruses and the origin and disappearance of kuru.
D. Gajdusek (1977)
Science 197, 943-960
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)